REDHILL BIOPHARMA LTD. Number Of Share Options Granted In Share-based Payment Arrangement
REDHILL BIOPHARMA LTD. (RDHL) reported Number Of Share Options Granted In Share-based Payment Arrangement of 275 Option for the 12-month period ending 2022-12-31, per its 20-F filed 2024-04-08.
Discontinued › Notes › Compensation Related Costs
ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement · last filed 2024-04-08
Option
| Period end | Number Of Share Options Granted In Share-based Payment Arrangement 12 month | Number Of Share Options Granted In Share-based Payment Arrangement 12 month as first filed |
|---|---|---|
| 2022-12-31 | 275.00 Option 20-F · filed 2024-04-08 | 11.00K Option 20-F · filed 2023-04-28 |
| 2021-12-31 | 2.53M Option 20-F · filed 2023-04-28 | |
| 2020-12-31 | 1.65M Option 20-F · filed 2022-03-17 | |
| 2019-12-31 | 1.19M Option 20-F · filed 2021-03-18 | 11.85M Option 20-F · filed 2020-03-04 |
| 2018-12-31 | 6.00M Option 20-F · filed 2020-03-04 | |
| 2017-12-31 | 7.24M Option 20-F · filed 2019-02-26 | |
| 2016-12-31 | 2.24M Option 20-F · filed 2018-02-22 |
USD
| Period end | Number Of Share Options Granted In Share-based Payment Arrangement 6 month | Number Of Share Options Granted In Share-based Payment Arrangement 12 month | Number Of Share Options Granted In Share-based Payment Arrangement 12 month as first filed |
|---|---|---|---|
| 2020-12-31 | $1.65M 20-F · filed 2022-03-17 | ||
| 2020-06-30 | $1.56M 6-K · filed 2020-08-13 | ||
| 2019-12-31 | $1.19M 20-F · filed 2021-03-18 | $11.85M 20-F · filed 2020-03-04 | |
| 2018-12-31 | $6.00M 20-F · filed 2020-03-04 |